CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-02-17 | Avelar Rui See Remarks | Grant or award · Performance Restricted Stock Units | +94,913 | 94,913 | ||
| 2026-02-17 | Avelar Rui See Remarks | Grant or award · Stock Option (Right to Buy) | +138,649 | 138,649 | ||
| 2026-02-17 | GILL DAVID N Director | Grant or award | +45,559 | 86,887 | ||
| 2025-12-22 | MOATAZEDI DAVID See Remarks | Sale 10b5-1 | −10,539 | $7.15 | $75K | 354,388 |
| 2025-12-22 | Avelar Rui See Remarks | Sale 10b5-1 | −2,261 | $7.15 | $16K | 356,821 |
| 2025-09-08 | Mitchell Tatjana Chief Financial Officer | Grant or award | +104,603 | 104,603 | ||
| 2025-09-08 | Mitchell Tatjana Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +143,403 | 143,403 | ||
| 2025-08-22 | Yamagishi-Dressler Tomoko Chief Marketing Officer | Sale 10b5-1 | −5,722 | $7.51 | $43K | 89,949 |
| 2025-08-15 | Stewart Brady Director | Purchase | +30,000 | $6.82 | $204K | 88,629 |
| 2025-06-16 | MOATAZEDI DAVID See Remarks | Sale | −16,582 | $9.89 | $164K | 364,927 |
| 2025-06-13 | MOATAZEDI DAVID See Remarks | Sale | −111,323 | $10.05 | $1.1M | 381,509 |
| 2025-06-09 | White Albert G III Director | Purchase | +20,000 | $9.45 | $189K | 50,378 |
| 2025-05-13 | Beaver Sandra Chief Financial Officer | Sale 10b5-1 | −6,494 | $10.02 | $65K | 167,089 |
| 2025-05-12 | Avelar Rui See Remarks | Sale 10b5-1 | −3,385 | $9.87 | $33K | 359,082 |
| 2025-05-12 | MOATAZEDI DAVID See Remarks | Sale 10b5-1 | −15,787 | $9.87 | $156K | 492,832 |
| 2025-03-27 | MOATAZEDI DAVID See Remarks | Sale 10b5-1 | −6,251 | $12.40 | $78K | 508,619 |
| 2025-03-18 | Avelar Rui See Remarks | Sale 10b5-1 | −27,904 | $13.26 | $370K | 362,467 |
| 2025-03-18 | Beaver Sandra Chief Financial Officer | Sale 10b5-1 | −8,996 | $13.26 | $119K | 173,583 |
| 2025-03-18 | Yamagishi-Dressler Tomoko Chief Marketing Officer | Sale 10b5-1 | −4,536 | $13.26 | $60K | 95,671 |
| 2025-03-18 | MOATAZEDI DAVID See Remarks | Sale 10b5-1 | −103,376 | $13.26 | $1.4M | 514,870 |
Page 2 of 16 · 303 trades